France is set to become the first country in Europe to reimburse weight-loss medications, including popular options like Wegovy and Mounjaro, starting June 15. This decision, announced by French Health Minister Stéphanie Rist, marks a significant shift in healthcare policy, aiming to improve access to these treatments for those struggling with obesity.
The reimbursement will officially cover 65% of the drug costs, but most patients with related health issues, such as diabetes or hypertension, are expected to receive full coverage. This could potentially alleviate the financial burden for many, as these medications can cost around €300 per month.
With obesity rates on the rise—approximately 18% of the French population is classified as obese—this move could set a precedent for other European nations. It highlights a growing recognition of obesity as a serious health issue that requires medical intervention, rather than just lifestyle changes.
As the UK grapples with its own obesity crisis, this development may prompt discussions about similar policies. If successful, it could encourage the UK to reconsider its stance on weight-loss drug reimbursements, impacting healthcare access and costs for British patients in the future.
Source: Euronews
